Schedule 13G ownership disclosure

Benitec Biopharma LTD/ADR

Security class unavailable · CUSIP: 082053307

Event date: 2016-11-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
17,191,980
Percent of class
9.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000169
Form type
SC 13G
Filer
Motif Bio plc
CIK
CIK 1674657
Filed
Nov 28, 2016
Reporting period
Nov 18, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub